Menin-MLL complex cooperates with NF-Y to promote HCC survival [CUT&RUN]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 72 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Hepatocellular carcinomaThis series is part of our curated briefing on it.
- Samples
- 72 samples: 16 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Menin-MLL1 complex cooperates with NF-Y to promote hepatocellular carcinoma survivalCell reports · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE293692_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1245698 and SRA study SRP576214. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 70 samples.
How we read this: 16 replicated groups read from 72 sample titles; they account for 70 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8888482 HLF treated with DMSO IP for MLL1 replicate 1 HLF treated with DMSO I…
- GSM8888483 HLF treated with DMSO IP for H3K27me3 replicate 1 HLF treated with DMSO I…
- GSM8888484 HLF treated with DMSO IP for IgG replicate 1 HLF treated with DMSO I…
- GSM8888485 HLF treated with SNDX IP for MLL1 replicate 1 HLF treated with SNDX I…
- GSM8888486 HLF treated with SNDX IP for H3K27me3 replicate 1 HLF treated with SNDX I…
- GSM8888487 HLF treated with SNDX IP for IgG replicate 1 HLF treated with SNDX I…
- GSM8888488 HLF treated with DMSO IP for MLL1 replicate 2 HLF treated with DMSO I…
- GSM8888489 HLF treated with DMSO IP for H3K27me3 replicate 2 HLF treated with DMSO I…
- GSM8888490 HLF treated with DMSO IP for IgG replicate 2 HLF treated with DMSO I…
- GSM8888491 HLF treated with SNDX IP for MLL1 replicate 2 HLF treated with SNDX I…
- GSM8888492 HLF treated with SNDX IP for H3K27me3 replicate 2 HLF treated with SNDX I…
- GSM8888493 HLF treated with SNDX IP for IgG replicate 2 HLF treated with SNDX I…
- GSM8888494 HLF treated with DMSO IP for Menin replicate 1 HLF treated with DMSO I…
- GSM8888495 HLF treated with DMSO IP for H3K4me3 replicate 1 HLF treated with DMSO I…
- GSM8888496 HLF treated with DMSO IP for IgG replicate 3 HLF treated with DMSO I…
- GSM8888497 HLF treated with SNDX IP for Menin replicate 1 HLF treated with SNDX I…
- GSM8888498 HLF treated with SNDX IP for H3K4me3 replicate 1 HLF treated with SNDX I…
- GSM8888499 HLF treated with SNDX IP for IgG replicate 3 HLF treated with SNDX I…
- GSM8888500 HLF treated with DMSO IP for Menin replicate 2 HLF treated with DMSO I…
- GSM8888501 HLF treated with DMSO IP for H3K4me3 replicate 2 HLF treated with DMSO I…
- GSM8888502 HLF treated with DMSO IP for IgG replicate 4 HLF treated with DMSO I…
- GSM8888503 HLF treated with SNDX IP for Menin replicate 2 HLF treated with SNDX I…
- GSM8888504 HLF treated with SNDX IP for H3K4me3 replicate 2 HLF treated with SNDX I…
- GSM8888505 HLF treated with SNDX IP for IgG replicate 4 HLF treated with SNDX I…
- GSM8888506 HLF treated with DMSO IP for H3K4me3 replicate 3 HLF treated with DMSO I…
- GSM8888507 HLF treated with DMSO IP for H3K27me3 replicate 3 HLF treated with DMSO I…
- GSM8888508 HLF treated with DMSO IP for IgG replicate 5 HLF treated with DMSO I…
- GSM8888509 HLF treated with SNDX IP for H3K4me3 replicate 3 HLF treated with SNDX I…
- GSM8888510 HLF treated with SNDX IP for H3K27me3 replicate 3 HLF treated with SNDX I…
- GSM8888511 HLF treated with SNDX IP for IgG replicate 5 HLF treated with SNDX I…
- GSM8888512 HLF treated with DMSO IP for H3K4me3 replicate 4 HLF treated with DMSO I…
- GSM8888513 HLF treated with DMSO IP for H3K27me3 replicate 4 HLF treated with DMSO I…
- GSM8888514 HLF treated with DMSO IP for IgG replicate 6 HLF treated with DMSO I…
- GSM8888515 HLF treated with SNDX IP for H3K4me3 replicate 4 HLF treated with SNDX I…
- GSM8888516 HLF treated with SNDX IP for H3K27me3 replicate 4 HLF treated with SNDX I…
- GSM8888517 HLF treated with SNDX IP for IgG replicate 6 HLF treated with SNDX I…
- GSM8888518 HLF treated with DMSO IP for H3K4me3 replicate 5 HLF treated with DMSO I…
- GSM8888519 HLF treated with SNDX IP for H3K4me3 replicate 5 HLF treated with SNDX I…
- GSM8888520 HLF treated with DMSO IP for H3K4me3 replicate 6 HLF treated with DMSO I…
- GSM8888521 HLF treated with DMSO IP for H3K4me3 replicate 7 HLF treated with DMSO I…
+ 32 more — browse all 72 samples with per-sample file links →
- GSE14520 Gene expression data of human hepatocellular carcinoma (HCC) 488 samples same disease briefing · shares hcc
- GSE114564 Identification of novel serum biomarkers in early-stage HCC patients. 118 samples same disease briefing · shares hcc
- GSE10143 Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 387 samples same disease briefing
- GSE107170 Molecular Signature of Hepatitis D Virus-Associated Hepatocellular Carcinoma 307 samples same disease briefing
- GSE109211 Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial 140 samples same disease briefing
- GSE10186 Integrative Transcriptome Analysis Reveals Common Molecular Subtypes of Human Hepatocellular Carcinoma 118 samples same disease briefing
- GSE105130 Comprehensive analysis of Transcriptome Profiles in Hepatocellular Carcinoma patients 52 samples same disease briefing
- GSE140228 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma 41 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.